At SCOPE Summit, Craig Lipset shared a blunt assessment of clinical trial innovation: the tools exist, regulators are engaged, and digital approaches offer clear quality advantages — yet adoption remains the industry’s biggest hurdle. From evolving FDA inspection expectations to the normalization (and lingering misconceptions) of decentralized trials, Lipset argues progress will depend less on new technology and more on scaling what already works.
- How To Operationalize AI-Enabled eTMF Systems Under The EU AI Act (Part 2)
- How AI-Enabled eTMF Systems Are Impacted By The EU AI Act (Part 1)
- Making AI Safety Routine: How Sites And Sponsors Can Continuously Monitor Clinical AI
- How Can AI Change Computerized System Validation?
- Digital Tools Are Failing Patients: 3 Ways Clinical Supply Can Protect Data Integrity
- Virtual Reality Endpoints Improve Measurement Of Patients' Real-World Benefit
- Can't-Miss Advice On Selecting Your First AI-Enabled Vendor
- The Site Perspective: Why Ambient AI Is The Missing Link In Clinical Trial Data Integrity
ON-DEMAND WEBINARS
The most difficult clinical research just became more challenging. Learn tactics on how teams can simplify oncology research while solving new and old issues.
Beyond enabling data collection outside the clinic, new models are enhancing stakeholders' abilities to access more sensitive, frequent, and objective measures of Parkinson’s progression.
CGT pioneers require supply chain partnerships that mitigate trial risk and complexity. Explore how to optimize pre-trial and pre-screening activities and reduce trial cost and risk with an IRT solution.
Drug development in neurology is notoriously challenging. Despite being one of the most active areas of clinical development, neurological disease drug trials have among the longest development timelines and highest failure rates in the industry. In this webinar, learn how digital clinical measures enabled by wearables have great potential to transform and accelerate drug development in neuroscience.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![GettyImages-1344606074 data insights]( "Clinical Trial Startup: Insights From The Industry")
Clinical Trial Startup: Insights From The IndustryUncover key survey findings gleaned from the perspectives of over 500 clinical researchers regarding technological trends and recommendations for enhancing the overall site experience.
-
![GettyImages-1414020314 wearables]( "3 Things To Know When Using Wearables In Your Study")
3 Things To Know When Using Wearables In Your StudyAs wearables unleash new possibilities, the industry will need an effective strategy to utilize these useful tools. Consider these tips when incorporating wearables in a clinical study.
-
![AI Artificial Intelligence-GettyImages-1209787439]( "Growing Pains: The Real Story Behind Gen AI Development In Clinical Trial Ops")
Growing Pains: The Real Story Behind Gen AI Development In Clinical Trial OpsAs Gen AI develops and reaches advanced stages it introduces risks such as model hallucinations, which can affect trial accuracy and reliability. Explore how to address these challenges.
-
![GettyImages-1194783103 eCOA ps]( "How eCOAs Can Benefit Clinical Trials")
How eCOAs Can Benefit Clinical TrialsLearn how the built-in flexibility and freedom of eCOAs can enhance many aspects of a clinical trial.
-
![alternative way, changing plans, flexibility-GettyImages-2151843291]( "Digital Protocols Are At An Inflection Point: A Conversation With Novartis And TransCelerate Leaders")
Digital Protocols Are At An Inflection Point: A Conversation With Novartis And TransCelerate LeadersDigital protocols could reduce manual effort and enable rapid and more consistent downstream study execution, reporting, and submission processes. TransCelereate BioPharma's Rob DiCicco and Novartis' Bill Illis explain.
-
![GettyImages-1205564882-staircase-build-blocks-pieces-tetris]( "Building Blocks: The Ultimate Guide To AI In Clinical Trials")
Building Blocks: The Ultimate Guide To AI In Clinical TrialsThis comprehensive guide provides an authoritative, in-depth look at AI's role in accelerating drug development and improving patient outcomes, with special focus on emerging agentic AI technologies.
-
![GettyImages-1332353096 data]( "Readying Your Clinical Trial For Linkage With Real-World Data")
Readying Your Clinical Trial For Linkage With Real-World DataDiscover why the near ubiquity of real-world data (RWD) sources has prompted sponsors to consider RWD’s role in study programs and regulatory bodies to issue guidance on their use in clinical development.
-
![GettyImages-1137736725 data platform]( "Achieving A 2.67x Reduction In Study Build Time For An Innovative Neuromodulation Study")
Achieving A 2.67x Reduction In Study Build Time For An Innovative Neuromodulation StudyThis study explores the potential of Focused Ultrasound Neuromodulation in deepening meditative states, and the platform that helps enhance the overall experience for researchers and participants alike.
-
![JavaScript Breaks Data Out From Bar(codes)]( "Real-World Data Capture With EDC")
Real-World Data Capture With EDCThis case study explores how a Ph.D. candidate partnered with Castor to develop software that seamlessly moves RWD between hospital systems and Castor’s EDC.
-
![iStock-1249601252-doctor-virtual-computer]( "Paving The Way For Virtual Trials In Neurology: A Fully Remote ALS Study")
Paving The Way For Virtual Trials In Neurology: A Fully Remote ALS StudyThe COVID-19 pandemic has completely changed the way we think about clinical research and care. Clinical trials, a vital component of the drug development process, were heavily disrupted because patients, often with weakened immune systems, could not visit hospitals and research sites.
FROM THE EDITOR
- Forget More Clinical Tech, We Need More Adoption
- Joe Dustin: Sites Are Driving Clinical Tech Evolution
- How Salk And Sabin Helped Create The Modern Clinical Trial
- Why HEOR Keeps Arriving Too Late — And How ClinOps Can Fix It
- FDA Vs. MHRA Vs. EMA: Differences In Externally Controlled Trials
- RWE Is Growing Up, And Here's Why That Matters
- The Dream Is EHR-To-EDC — eSource Is The Wake-Up Call
FEATURED PRODUCTS & SERVICES
RECENT NEWSLETTERS
- 02.19.26 -- The Clinical Tools Quietly Reshaping Trial Operations
- 02.12.26 -- How Can AI Change Computerized System Validation?
- 02.05.26 -- Digital Tools Are Failing Patients: Three Ways Clinical Supply Protects Data
- 01.29.26 -- Digital Protocols Are At An Inflection Point: A Conversation With Novartis And TransCelerate Leaders
- 01.22.26 -- The Role Of Open Source In Powering CDISC 360i